Isolation and composition of a novel glycosidase from chryseobacterium
AssigneeNew England Biolabs, Inc.
InventorDavid Landry
Life of this patent
Estimating the term…
Abstract
In accordance with the present invention, there are provided substantially pure glycosidases obtainable from the genus Chryseobacterium. In particular, there is provided a substantially pure exo α-N-Acetylgalactosaminidase from Chryseobacterium meningosepticum. A method of cloning this enzyme and producing a recombinant form of the enzyme is also provided by the present invention.
Claims8
A composition comprising a substantially pure exo α-N-Acetylgalactosaminidase endogenous to Chryseobacterium.
A composition comprising a recombinant exo α-N-Acetylgalactosaminidase, wherein said exo α-N-Acetylgalactosaminidase is encoded by a polynucleotide obtainable from Chryseobacterium meningosepticum (ATCC No. 13253).
Dependencies are inferred from the claim text.